Celgene Corp. buy melinda
Start price
11.10.13
/
50%
€56.45
Target price
23.12.13
€60.00
Performance (%)
9.27%
End price
23.12.13
€61.68
Summary
This prediction ended on 23.12.13 with a price of €61.68. The BUY prediction by melinda finished with a performance of 9.27%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,04 % | 43,87 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 13,43 % | 74,09 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 23,57 % | 44,13 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 8,65 % | 56,04 % |
Comments by melinda for this prediction
In the thread Celgene Corp. diskutieren
erhöhen
RBC Capital Markets